NgenIa 24 mg Research Overview
NgenIa 24 mg is a pharmaceutical-grade recombinant human growth hormone (somatropin) formulation manufactured by Pfizer USA, specifically developed for sophisticated laboratory research examining growth hormone receptor pathways and cellular signalling mechanisms. This advanced compound represents one of the most extensively studied growth hormone preparations available to research institutions worldwide. As the leading UK supplier of research chemicals, Stroid UK Shop maintains strict quality standards for all pharmaceutical-grade compounds in our extensive catalogue.
Laboratory Research Applications
Research scientists utilise NgenIa 24 mg to investigate the complex mechanisms of growth hormone receptor activation, IGF-1 pathway modulation, and cellular proliferation responses in various tissue models. This compound serves as an invaluable tool for examining metabolic regulation, protein synthesis pathways, and cellular growth factor interactions in controlled laboratory environments. The pharmaceutical-grade formulation ensures consistent results across multiple research protocols. Investigators studying endocrine system function often combine this compound with other research materials from our comprehensive growth hormone collection, alongside compounds from our selective androgen receptor modulator range and peptide research library for comprehensive endocrine pathway analysis.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Somatropin (recombinant human growth hormone) |
| Strength | 24 mg per vial |
| Manufacturer | Pfizer (USA) |
| Formulation | Lyophilised powder for reconstitution |
| CAS Number | 12629-01-5 |
| Storage Requirements | 2-8°C refrigerated storage |
Compliance and Research Use Declaration
NgenIa 24 mg is supplied exclusively for legitimate laboratory research purposes and in-vitro scientific investigation. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must maintain appropriate laboratory protocols, safety procedures, and regulatory compliance when handling this pharmaceutical-grade material. All purchases require institutional verification and documented research protocols.
